CA
LEGN icon

Clearstead Advisors’s Legend Biotech LEGN Stock Holding History

Clearstead Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.19K Buy
+249
New +$6.72K ﹤0.01% 2086
2026
Q1 		– Sell
-3,479
Closed -$75.6K – 2590
2025
Q4 		$75.6K Buy
3,479
+2,632
+311% +$75.4K ﹤0.01% 1219
2025
Q3 		$27.6K Buy
847
+367
+76% +$13.6K ﹤0.01% 1494
2025
Q2 		$17K Buy
+480
New +$15.6K ﹤0.01% 1687
2024
Q4 		– Sell
-1,470
Closed -$71.6K – 2148
2024
Q3 		$71.6K Hold
1,470
– – ﹤0.01% 1117
2024
Q2 		$65.1K Buy
1,470
+180
+14% +$8.3K ﹤0.01% 1101
2024
Q1 		$55.4K Buy
1,290
+410
+47% +$24.7K ﹤0.01% 738
2023
Q4 		$53K Buy
880
+35
+4% +$2.22K ﹤0.01% 725
2023
Q3 		$56.8K Sell
845
-32
-4% -$2.22K ﹤0.01% 674
2023
Q2 		$60.5K Buy
+877
New +$57.3K ﹤0.01% 690

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Clearstead Advisors's LEGN Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Legend Biotech (LEGN) in Q2 2026: 249 shares worth $7.19K. The stake represents ﹤0.01% of the portfolio and ranks #2086 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in LEGN as recently as Q4 2025.

Clearstead Advisors first reported a position in LEGN in Q2 2023 and has held it in 10 quarters since. The position peaked at $75.6K in Q4 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Clearstead Advisors held 249 shares of Legend Biotech worth $7.19K as of Q2 2026.
  • Legend Biotech was a new Clearstead Advisors position in Q2 2026.
  • Legend Biotech made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2086 holding.
  • Clearstead Advisors first reported a position in Legend Biotech in Q2 2023 and has held it in 10 quarters since.
  • Clearstead Advisors's Legend Biotech position peaked at $75.6K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.